The effect of targeted therapy of crizotinib on advanced non-small cell lung cancer patients with anaplastic lymphoma kinase and C-ros oncogene 1-receptor tyrosine kinase fusion gene positive

Li Li; Zhao Zhenhui; Li Yan; Ma Xiaoping; Liu Dan; Li Bingyu; Zhao Bing

doi:10.3760/j.issn.1673-4777.2023.11.007

Home>Articles>The effect of targeted therapy of crizotinib on advanced non-small cell lung cancer patients with anaplastic lymphoma kinase and C-ros oncogene 1-receptor tyrosine kinase fusion gene positive

DOI: 10.3760/j.issn.1673-4777.2023.11.007

The effect of targeted therapy of crizotinib on advanced non-small cell lung cancer patients with anaplastic lymphoma kinase and C-ros oncogene 1-receptor tyrosine kinase fusion gene positive

Li Li

Zhao Zhenhui

Li Yan

Ma Xiaoping

Liu Dan

Li Bingyu

Zhao Bing

Keywords：Non-small cell lung cancerCrizotinibAnaplastic lymphoma kinaseC-ros oncogene 1-receptor tyrosine kinaseFusion geneTargeted therapy

Publication Date：2023-11-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：5( 1627-1631 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2023,18(11)